Affimed N.V.   (NASDAQ:AFMD)

4.27    $-0.17   -3.83%
Market open   Tuesday, Jan 18 2022 12:16 PM

Affimed N.V. Chart

AFMD Stock Price Today

Affimed N.V. (AFMD) stock plummeted over -3.83% intraday to trade at $4.27 a share on NASDAQ. The stock opened with a loss of -1.13% at $4.39 and touched an intraday high of $4.45, rising 0.23% against the last close of $4.44. The stock went to a low of $4.20 during the session.

Stock Snapshot

4.44
Prev. Close
4.39
Open
528.49M
Market Cap
119.79M
Number of Shares
4.20
day Low
4.45
Day High
4.27
-
P/E ratio
2.49%
Free Float in %
-0.50
EPS (TTM)
1.28
Book Value per Share
-
Cash Flow per Share
234353
Volume

Affimed N.V. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2022-01-14$4.36$4.44$4.45$4.20990,200
2022-01-13$4.52$4.41$4.60$4.341,683,400
2022-01-12$4.72$4.47$4.84$4.471,089,600
2022-01-11$4.74$4.72$4.90$4.671,286,800
2022-01-10$4.76$4.72$4.92$4.531,456,100
2022-01-07$5.02$4.82$5.17$4.811,551,000
2022-01-06$4.97$5.04$5.11$4.841,191,400
2022-01-05$5.30$4.97$5.37$4.951,033,400
2022-01-04$5.68$5.36$5.69$5.30781,500
2022-01-03$5.55$5.65$5.76$5.52743,300
2021-12-31$5.64$5.52$5.77$5.52568,900

Contact Details

Technologiepark


Im Neuenheimer Feld 582


Heidelberg 69120


Germany




https://www.affimed.com
49 6221 6743 60

Company Information

Employees128
Beta2.54
Sales or Revenue45.60M
5Y Sales Change30.30%
Fiscal Year Ends2020-12-30
SectorHealthcare
IndustryBiotechnology

About Company

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. Its lead product candidate is AFM13, which has completed Phase II clinical study of CD30-positive T-cell lymphoma, and hodgkin lymphoma (HL), as well as is in Phase II clinical trials for peripheral T-cell lymphoma, and transformed mycosis fungoides; that is in Phase I clinical study in combination with adoptive NK cells for CD30-postive lymphomas; and has completed Phase Ib clinical study in combination with anti-PD-1 antibody Keytruda (pembrolizumab) in patients with relapsed HL. The company is also developing AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase I/IIa clinical trials for the treatment of advanced cancer patients; and AFM26, an innate cell-engaging bispecific antibody targeting B cell maturation antigen (BCMA) for the treatment of multiple myeloma. The company has collaboration agreements with The University of Texas MD Anderson Cancer Center; Genentech, Inc.; Roivant Sciences Ltd.; and Roche Holding AG, as well as research funding agreement with The Leukemia & Lymphoma Society. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany.

Frequently Asked Questions

What is the current Affimed N.V. (AFMD) stock price?

Affimed N.V. (NASDAQ: AFMD) stock price is $4.27 as of the last check on Tuesday, Jan 18 2022. During the trading session, AFMD stock reached the peak price of $4.45 while $4.20 was the lowest point it dropped to.

AFMD's industry and sector of operation?

The NASDAQ listed AFMD is part of Biotechnology industry that operates in the broader Healthcare sector. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany.

Who are the executives of AFMD?

Dr. Adi Hoess
CEO, MD & Member of Management Board

Dr. Wolfgang Fischer
MD, COO & Member of Management Board

Prof. Melvyn Little
Founder & Consultant

Mr. Angus W. Smith
Chief Financial Officer


What is the AFMD stock price today?

AFMD stock is trading at $4.27 today, which is $-0.17 or -3.83% lower than its previous close of $4.44. AFMD's current trading price is -63.63% lower than its 52-week high of $11.74 where as its distance from 52-week low of $4.20 is 1.67%.

How many employees does AFMD have?

Number of AFMD employees currently stands at 128. AFMD operates from Technologiepark
Im Neuenheimer Feld 582
Heidelberg 69120
Germany

.

Link for AFMD official website?


How do I contact AFMD?

AFMD could be contacted at Technologiepark
Im Neuenheimer Feld 582
Heidelberg 69120
Germany

, or at phone # 49 6221 6743 60 and can also be accessed through its website: https://www.affimed.com

How many shares of AFMD are traded daily?

AFMD stock volume so far today is 234353 shares while in the previous session number of AFMD shares traded was 990200. The average number of AFMD shares traded daily for last 3 months was 1.84M.

How much did AFMD change today?

The percentage change in AFMD stock occurred in the recent session was -3.83% while the dollar amount for the price change in AFMD stock was $-0.17.

What price range AFMD stock been trading in?

In the recent session, the day high for AFMD stock was $4.45 while the low for AFMD stock touched on the day was $4.20.

What is the market cap of AFMD currently?

The market value of AFMD currently stands at $528.49M with its latest stock price at $4.27 and 119.79M of its shares outstanding.